Result
Jul 30, 2021 → Jul 29, 2026 · 4y 11mo
Today's value
$2,703.66+170.37%
Initial investment
$1,000
Profit
$1,703.66
Annual return (CAGR)
+22.01%
Historical return extremes for AbbVie (ABBV) from 2013 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +1,236% | $19.73 | $263.58 | $13,359.35 | ||
| Max drawdownMore info about Max drawdown | -45.08% | $86.71 | $47.62 | $549.19 | ||
| Return since IPOMore info about Return since IPO | +1,182% | $20.56 | $263.58 | $12,820.04 |
- Max profitMore info about Max profit+1,236%$13,359.35
- Max drawdownMore info about Max drawdown-45.08%$549.19
- Return since IPOMore info about Return since IPO+1,182%$12,820.04
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in AbbVie (ABBV). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.